FDA Permits New Sunscreen Ingredient After 20 Years

• by Kathryn Wighton

• June 9, 2026

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

• by Andrea Surnit

• May 5, 2026

• 4 min

Matrix metalloproteinase expression in basal cell carcinoma, squamous carcinoma, and melanoma: diagnostic and prognostic potential

• by Giovanni Francesco Spatola, Alessandro Pitruzzella, Antonino Gioacchino Listro, Carla Valenti, Mariaelena Scalisi, Federica Milia, Paolo Listro, Flavia Zingales, Giulio Maria Ferranti, Marta Listro, Beatrice Belmonte, Domiziana Picone, Giorgia Intili, Maria Laura Uzzo

• May 4, 2026

Case Report: Atypical pattern of pathologic response in cutaneous transdifferentiated melanoma with rhabdomyoblastic differentiation following neoadjuvant therapy

• by Isabela Paulino Serur, Beatriz Mendes Awni Cidale, Ana Zélia Leal Pereira, Gustavo Benfatti Olivato, Giulia Kodja Zanetta, Melissa Lissae Fugimori, Claudia Regina Gomes Cardim Mendes de Oliveira, Maria Fernanda Hunziker, Frederico José Ribeiro Teixeira Júnior, Rodrigo Ramella Munhoz

• May 4, 2026